Pharma Outsourcing Outlook: The Only Sure Thing About 2019 is Uncertainty
by Jim Miller, Content Advisor and Consultant, DCAT and former President, PharmSource Information Services, Inc., a GlobalData company
What is in store for CDMOs in 2019? A myriad of issues could impact market fundamentals and the recent highly favorable environment in which they have operated.Read More
New Drug Approvals: Which Drugs Made the Mark in 2018?
by Patricia Van Arnum, DCAT Editorial Director
Last year was record-setting for approvals of new molecular entities (NMEs) by the FDA with 59 NMEs approved. DCAT Value Chain Insights examines the 2018 NME approvals, the product mix between small molecules and biologics, and the pharma companies that led the pack. Read More
Don't Miss Top Industry News online and in your inbox every Friday
Patricia Van Arnum is Editorial Director at the Drug, Chemical & Associated Technologies Association (DCAT), where she is responsible for delivering informational services for DCAT members. She is editor of two weekly editorial newsletters, DCAT Value Chain Insights and Top Industry News. She also supports DCAT’s volunteer committees and task forces that develop educational programs and informational content for DCAT members. Read More
DCAT Value Chain Insights is produced and distributed by the Drug, Chemical and Associated Technologies Association.
